What is OSR Holdings's market cap?

OSR Holdings (OSRH) has a market capitalization of $4.1M and trades on NASDAQ.

Who are OSR Holdings's competitors?

OSR Holdings's key competitors include Medtronic, AbbVie, Stryker, and others. These companies compete in similar markets and product categories.

Who does OSR Holdings partner with?

OSR Holdings's notable partners include Richter-Helm BioLogics GmbH & Co. KG, Asahi Intecc, Microport Neurotech, and others.

What subsidiaries does OSR Holdings have?

OSR Holdings's subsidiaries include Vaximm, Darnatein, RMC.

Where is OSR Holdings headquartered?

OSR Holdings is headquartered in United States of America. It has been publicly traded since 2025.

OSR Holdings (OSRH) Stock Fundamentals & Financials

Market cap

$4.09M-78.5%

Earnings

Q2 2026 report

August 14, 2026

Revenue$315.7KMiss by $464.3K EPS-$0.02Beat by $0.26

Read the full report

Next report

Date not yet announced

Competitors

By market cap

AbbVie$464.58B+26.4%

Stryker$126.45B-15.9%

Medtronic$117.78B-0.2%

Immunome$3.3B+277%

OS Therapies$76.7M-3.8%

HIN

Vyome Holdings$15.2M-74.0%

PDS Biotechnology Corporation$12.5M-79.1%

OSR Holdings$4.1M-78.5%

By revenue growth

By net margin

Profile

OSR Holdings is a global healthcare holding company that operates a hub-and-spoke business model to develop and commercialize a risk-diversified portfolio of pharmaceutical and medical device technologies. The company identifies and supports subsidiaries focused on innovative research in oral T-cell immunotherapies, recombinant biologics, and regenerative medicine for age-related degenerative diseases. Additionally, the company operates a medical device distribution platform in South Korea, which it is evolving into a fourth-party logistics (4PL) healthcare supply chain provider.

Competitive position

A differentiated global holding company utilizing a hub-and-spoke model to advance a risk-diversified portfolio of breakthrough therapeutic and regenerative technologies.

GeographiesSouth Korea, Switzerland, United States, Germany

Customer segmentsHospitals, Specialized Medical Practitioners, Pharmaceutical Companies

Business modelHolding Company, R&D, Distribution, 4PL

SuppliersAcademic research institutions, Contract Manufacturing Organizations (CMOs), Third-party clinical trial providers, Medical device manufacturers

CustomersHospitals, Surgical centers, Pharmaceutical strategic partners, Specialist physicians

CountryUnited States of America

Listed2025

CEOKuk Hyoun Hwang

SectorHealthcare

IndustryBiotechnology

Websiteosr-holdings.com

FilingsSEC EDGAR

FAQ

What is OSR Holdings's market cap?: OSR Holdings (OSRH) has a market capitalization of $4.1M and trades on NASDAQ.
Who are OSR Holdings's competitors?: OSR Holdings's key competitors include Medtronic, AbbVie, Stryker, and others. These companies compete in similar markets and product categories.
Who does OSR Holdings partner with?: OSR Holdings's notable partners include Richter-Helm BioLogics GmbH & Co. KG, Asahi Intecc, Microport Neurotech, and others.
What subsidiaries does OSR Holdings have?: OSR Holdings's subsidiaries include Vaximm, Darnatein, RMC.
Where is OSR Holdings headquartered?: OSR Holdings is headquartered in United States of America. It has been publicly traded since 2025.